2018NeurologyRequires access

Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Safe and Effective? (P5.239)

Francis M Gengo, Erica S. Westphal, Traci S. Aladeen, Kaitlin McCadden, Michelle M. Rainka, Vernice E. Bates

Open publisher page 1 citations

Abstract

The purpose of this study is to determine if the introduction of generic clopidogrel bisulfate products was associated with a change in the prevalence of resistance to the antiplatelet effects of clopidogrel.

About this research paper

What this paper is about

The purpose of this study is to determine if the introduction of generic clopidogrel bisulfate products was associated with a change in the prevalence of resistance to the antiplatelet effects of clopidogrel.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The purpose of this study is to determine if the introduction of generic clopidogrel bisulfate products was associated with a change in the prevalence of resistance to the antiplatelet effects of clopidogrel.

Key concepts: Clopidogrel, Substitution (logic), Brand names, Medicine, Advertising, Pharmacology, Internal medicine, Philosophy

Related papers

Back to paper searchBrowse research topicsOriginal source
Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Safe and Effective? (P5.239) — Research Paper | ScholarLens